Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Alembic Pharmaceuticals Ltd.	Income Statement

NSE: APLLTDEQ BSE: 533573ISIN: INE901L01018INDUSTRY: Pharmaceuticals

BSE

Rs 784.70

Open: 790.35

Today's Range 776.00

807.25

NSE
Rs 784.10
-1.60 ( -0.20 %)

-1.75 ( -0.22 %)

Prev Close: 786.45

52 Week Range 635.30

1107.80

You can view the Income Statement for the last 5 years.

Market Cap. (Rs.)	15412.51 Cr.	P/BV	2.83	Book Value (Rs.)	277.42
52 Week High/Low (Rs.)	1108/636	FV/ML	2/1	P/E(X)	22.84
Bookclosure	29/07/2025	EPS (Rs.)	34.33	Div Yield (%)	0.00

(Rs. in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00


INCOME
Revenue From Operations [Net]	7344.90	6539.71	6112.11	5499.77	5231.79
Other Operating Revenues	0.00	132.37	116.51	152.85	74.00
Total Operating Revenues	7344.90	6672.08	6228.62	5652.62	5305.79

Other Income	54.41	42.55	28.31	2.74	50.46
Total Revenue	7399.31	6714.63	6256.93	5655.36	5356.25

EXPENSES
Cost Of Materials Consumed	1747.38	1672.17	1403.01	1250.08	1129.11
Purchase Of Stock-In Trade	508.88	410.96	454.91	380.09	360.50
Operating And Direct Expenses	0.00	0.00	0.00	50.90	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-271.81	-289.77	-142.84	78.65	-43.19
Employee Benefit Expenses	1731.93	1562.34	1446.29	1169.13	1133.00
Finance Costs	93.63	78.77	56.19	50.17	17.73
Depreciation And Amortisation Expenses	318.55	278.58	272.67	275.43	286.78
Other Expenses	2510.05	2308.14	2133.90	2015.39	1852.21
Total Expenses	6638.61	6021.19	5624.13	5269.84	4736.14

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	760.70	693.44	632.80	385.52	620.11

Exceptional Items	-66.99	12.87	0.00	0.00	0.00
Profit/Loss Before Tax	693.71	706.31	632.80	385.52	620.11

Tax Expenses-Continued Operations
Current Tax	23.12	122.69	65.81	4.20	129.18
Deferred Tax	0.00	2.99	-46.06	9.20	-23.47
Tax For Earlier Years	0.00	-0.51	-3.75	-0.79	-1.25
Total Tax Expenses	23.12	125.17	16.00	12.61	104.46
Profit/Loss After Tax And Before ExtraOrdinary Items	670.59	581.14	616.80	372.91	515.65

Profit/Loss From Continuing Operations	670.59	581.14	616.80	372.91	515.65

Profit/Loss For The Period	670.59	581.14	616.80	372.91	515.65

Minority Interest	3.94	1.41	0.00	0.00	0.00
Share Of Profit/Loss Of Associates	0.24	0.87	-0.98	-30.92	5.29
Consolidated Profit/Loss After MI And Associates	674.77	583.42	615.82	341.99	520.94

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	34.33	29.68	31.33	17.40	26.50
Diluted EPS (Rs.)	34.33	29.68	31.33	17.40	26.50

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	216.22	157.25	196.56	275.19

Market

Derivatives

Mutual Fund

IPO

Quick Links

Alembic Pharmaceuticals Ltd.

Income Statement